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INTRODUCTION
Advances in a wide variety of disciplines over the past 3 decades has made renal transplantation 
the most effective means of rehabilitating patients with end stage renal disease1. The transplantation of 
solid organs, initially an experimental act, has evolved with successful procedures that provide the best 
chance for  survival  and  rehabilitation  for  hopelessly ill  patients2.  The first  recorded Human renal 
transplant was performed by  Joboulay Carrels teacher in 19063 using xenografts. The first  human 
kidney  allotransplant  was  carried  out  by  the  Soviet  Surgeon  
Yu Yu Vorovoy in 19354.With the shortage of live organ donors, use of organs from cadaver became a 
viable alternative5. The results of cadaver transplant are improving progressively with the advent of 
cyclosporine  and  would  shortly  be  comparable  with  that  of  live  related  donor  transplant.  As  the 
availability of suitable cadaver kidneys does not match the requirement of all end stage renal failure 
patients6,  live  donor  transplantation  continues  with the  advent  of  lesser  waiting  period  and fewer 
episodes of rejection.
In  India,  the  first  renal   transplantation  was  done  in  the  late  1960’s  by  
Sen et al in Bombay. Successful live related renal transplant programme was begun in CMC, Vellore in 1971. First free 
renal transplantation in a government hospital in South India was conducted by Prof. M.A.Muthusethupathi in Government 
Royapettah Hospital, Madras in 1981.
Infection and rejection, the two most important barriers to successful transplantation, are closely 
interwined,  linked  both  by  the  immunosuppressive  therapy  required  and  by  the  similar  array  of 
cytokines,  chemokines  and  growth  factors  elaborated  during  the  course  of  both  processes1.  Any 
intervention  that  decreases  the  risk  of  rejection  and  permits  the  use  of  less  intensive, 
immunosuppressive  therapy  will  result  in  a  decreased  risk  of  life  threatening  infection.  Any 
intervention  that  decreases  the  risk  of  infection  and  permits  the  safe  use  of  more  intensive 
immunosuppressive therapy will decrease the risk of allograft loss from rejection. The inflammatory 
response  to  microbial  invasion  in  the  transplant  patients  often  is  attended  by  concomitant 
immunosuppressive therapy. As a result, not only are the signs and symptoms of infection frequently 
blunted, but traditional diagnostic approaches to infection such as skin testing and serologic testing are 
rendered significantly less sensitive7.
The complications encountered in renal transplant recipients treated with immunosuppressive 
drugs  include  variety  of  opportunistic  infections8.  The  occurrence  of  infection  in  renal  transplant 
recipients has been related to a number of clinical factors including patient’s age, transplant type, HLA 
match, renal function, the occurrence of transplant rejection, the dosage of immunosuppressive therapy 
and neutropenia9.
As the life span of the immunocompromised patients has been extended, likewise the potential 
for exposure to nosocomial and opportunistic infections have increased. In comparison with the past 
however, more effective therapy in particular the antibiotics is now available to treat complications in 
immunocompromised patients. Thus the correct diagnosis of such condition is of utmost importance10.
Since isolation and identification of the real causative organism in infection in immunocompromised patient is 
mandatory, for saving the life of the patient, techniques which will confirmatively determine the real pathogen should be 
performed by proper collection avoiding contamination with normal flora to the maximal extent.
Advances  in medical  science including organ transplant  have helped the less pathogenic organism to produce 
infection and  infectious diseases are the commonest cause of morbidity and mortality in the renal transplant patients. Hence 
the causative agents of infection have to be analysed in detail, so that adequate treatment can be given at the appropriate 
time to save the patient’s life.
AIM OF THE STUDY
• To study the infections in renal transplant recipients during the period  Jan2004  to   Dec 
2005.
•  To analyse the infectious episodes in relation to systems and the microorganisms involved.
• To study the infectious episodes relevant to post transplant follow up duration.
• To determine  the  in  vitro  susceptibility  and resistance  pattern  of  the  bacterial  isolates  to 
different antimicrobial agents.
•  To analyse the morbidity and mortality in renal transplant recipients due to infections.
          
REVIEW OF LITERATURE
Renal  transplantation  has  become  a  well-established  therapeutic  option  for  end-stage  renal 
disease, but infectious diseases remain a significant cause of morbidity and mortality11.  Of the  solid 
transplants, kidney transplantation is associated with the lowest rates of infections.In contrast to liver, 
heart, or lung allograft recipients, whose clinical status often detoriates before transplant, the elective or 
semielective nature of kidney transplantation along with anatomic considerations considerably lowers 
the risk of infection. Despite these considerations, infections in the renal transplant patient can cause 
significant morbidity , leading to graft dysfunction or systemic complications. Certain viruses such as 
Cytomegalovirus, Ebstein barr virus and Hepatitis B and C viruses can  display an immunomodulating 
effect.  This  immunomodulation  may  contribute  
to  allograft  rejection,  obliterative  transplant  arteriopathy,  enhancement  of  other  opportunistic 
infections, and development of  post transplant lymphoproliferative disease (PLTD)12.
Infections are the major source of morbidity and mortality in renal  transplant  recipients. The 
risk  of  infection  in  organ  transplant  recipients,  particularly   opportunistic   infections  are  largely 
determined by the interaction between two factors. The epidemiologic exposure the patients encounter 
and the  patients net state of immunosuppression12.
Epidemiologic  exposures  of  importance  for  the  transplant  patients  can  be  divided  into  two 
categories  –  those  occurring  in  the  community  and  those  occurring  in  the  hospital.   Community 
exposure  of  major  concerns  include  -  
Mycobacterium tuberculosis, systemic mycosis (Blastomycosis, Coccidiodomycosis,  Histoplasmosis),  
Strongyloides  Stercoralis,  Hepatitis  B  and  C,  
Human immunodeficiency virus, enteric bacterial  pathogens (Salmonella sp) and Influenza virus1.
Two patterns  of  nosocomial  exposure have been defined:  domiciliary and non domiciliary. 
Domiciliary exposures occur in the room or ward where the patient is housed and are usually caused by 
contamination of the air or water supply by opportunistic pathogens.
Domiciliary  outbreaks  are  characterized  by  clustering  of  cases  in  time  and  space  and  are 
relatively easily identified and controlled. Non domiciliary  exposures are more problematic. These 
occur when patients are taken from their rooms to central facilities, such as the operating theatre, the 
radiology suite, or the cardiac catheterization laboratory. Non domiciliary exposures are more common 
within the hospital environment  than domiciliary exposures and are more difficult to identify because 
of the frequent lack of clustering of cases1.
The net state of immunosuppression in transplant patients is a complex function determined by 
the interplay of a number of factors12
1. The prophylactic immunosuppressive protocol employed
2. Intensification of immunosuppression during episodes of rejection
3. The presence of neutropenia
4. Open wounds and foreign bodies(eg. Catheters)
5. Metabolic abnormalities (eg.., malnutrition, uremia, hyperglycemia)
6. Infection with immunomodulatory viruses.
CATEGORIES OF INFECTION OCCURING IN RENAL TRANSPLANT RECIPIENTS8
Infections related to technical complications
Transplantation of a contaminated  allograft
Anastomotic leak or stenosis
Wound haematoma
Vascular access
Iatrogenic damage to the skin
Mismanagement of endotracheal tube leading to aspiration
Infection related to biliary, urinary and drainage catheters
Infections related  to Excessive Epidemiologic Exposures
Nosocomial exposures (domiciliary and nondomiciliary)          
Aspergillus sp
Legionella sp
Pseudomonas aeruginosa and other gram negative bacilli
Pneumocystis carinii
Exposures within the community
Systemic mycotic infections in certain geographic areas
            Histoplasmosis capsulatum
            Coccidioides immitis
            Blastomyces dermatitidis 
            Strongyloides stercoralis
Opportunistic infection from environmental saprophytes
            Cryptococcus neoformans
            Aspergillus sp
            Nocardia. asteroides
            Pneumocystis carini
Respiratory infections circulating in the community
Mycobacterial tuberculosis
Influenza virus
Parainfluenza virus
Adenovirus
Respiratory syncytial virus
Infections acquired by ingestion of contaminated food or water
Salmonella sp
Listeria monocytogenes
Viral infection of Particular importance in Transplant Patients
Herpes group viruses
Hepatitis viruses
Papilloma viruses
Human immunodeficiency virus
In the post transplant period different infections occurs at different periods, the post transplant 
period is divided into 3 phases when evaluating the patient for possible infection.
1. Infections  in  the  first  one  month  transplant  which  is  predominantly  infection  in  allograft 
recipient prior to transplant is transmitted by contaminated allograft or infection related to surgical 
wound, IV lines and catheters. Because of this risk, potential donors are carefully evaluated for the 
presence of microbial infections that could contaminate the allograft.
2. Infections in 1 – 6 months post transplant: The causes of infection during this period are very 
different  from  those  during  the  first  month  post  transplant.  By  far  the  most  important  cause  of 
infectious disease in this period are the immunomodulating viruses. For example, Cytomegalovirus by 
itself is the cause of more than two thirds of febrile episodes during this time. In addition to directly 
causing disease, these viruses combine with the sustained administration of immunosuppressive drugs 
to  produce  a  greater  net  state  of  immunosuppression,  a  level  that  permits  the  occurrence  of 
opportunistic infection due to organisms such as  Pneumocystis carinii,  Listeria monocytogenes  and 
Aspergillus fumigatus.
3. Infections in the late period (more than 6 months post transplant ).
Patients  with functioning allograft  on immunosuppressive therapy more than 6 months post 
transplant can be divided into 3 groups.
a. Approximately 75% of  these  patients  with  a  good allograft  function  are  receiving  minimal 
maintenance immunosuppressive agents and are free of chronic viral infections. The infections that 
these  patients  develop  are  similar  to  those  observed  in  the  general  population  –  Influenza, 
Pneumococcal pneumonia, urinary tract infections etc 
b. Approximately 10% to 15% have chronic viral infections with  Cytomegalovirus,Ebstein Barr 
virus,  the  Hepatitis  viruses  (HBV  or  HCV)  or  HIV  which  inexorably  lead  to  organ  failure 
(chorioretinitis  from  CMV ,cirrhosis  from  HBV or  HCV),  malignancy (lymphoproliferative  disease 
from EBV, hepatocellular carcinoma from HBV and possibly HCV; and possibly  other viral associated 
malignancies  such  as  squamous  cell  carcinoma  from  papilloma  virus),  or  the  acquired 
immunodeficiency syndrome (AIDS).
c. Finally 5% to 15%  of patients who are characterized by relatively poor allograft  function a 
history of acute or chronic rejection and an excessive amount of  immunosuppression,  are  at  highest 
risk  of  opportunistic  infection  such  as those caused by Cryptococcus neoformans, Pneumocystis  
carinii, Listeria monocytogenes  and  Nocardia asteroides.
Death from infections may be a poor indicator of infection rate as infection may occur as a 
terminal event in persons dying due to other causes and since most of the infections can be successfully 
treated.
More than 80% of allograft recipients suffer atleast one episode of infection within the first 
transplant  year14.  Recipients  at  increased  risk  of  infection  include   those  who  have  leucopenia, 
hyperglycaemia or azotemia and age more than forty15. In a study by Paterson et al from the University 
of Minnesota, 87% of the deaths were attributed to infection, 50% of which were viral in origin, 30% 
bacterial, 6% due to polymicrobial infection and 3% due to fungal infection16.
URINARY TRACT INFECTIONS (UTI)
Urinary tract infections are  most common form of bacterial infection among  renal transplant 
recipients13,27. The reported incidence varies from 37 - 79%17,18 and may account for more than 60% of 
bacteremia in these patients19. UTI is the most common complication in the first month after transplant 
and some reports  indicate  association of rejection with  Streptococcus  fecalis infection.  Most  cases 
involve  gram  negative  organisms.  Furthermore,  most  cases  of  gram-negative  bacteremia  in  the 
transplant  population  began  in  the  urinary  tract.  In  a  study  by  
Takai  et  al  (1998)29,  the  majority  of  organisms  cultured  in  UTI  were  gram-negative  (76%),  with 
approximately 1/3 being  Escherichia coli  and 1/5 being  Enterococcus and Klebsiella/Enterobacter. 
The routine post transplant use of prophylactic antibiotics has reduced the frequency of UTIs to less 
than 10 %  and essentially  eliminates urosepsis unless urine flow is obstructed. Prophylaxis should 
start within a few days of transplant and continue for 3-6 months12.
Postoperative foley tip  cultures  with subsequent  development  of  UTI  during the  next  two 
weeks was studied by Burleson et al(1977)20. None of the 15 patients with catheter tip negative cultures 
developed  UTI.  16/24  with  positive  culture  developed  UTI  within  two  weeks  of  removal  of  the 
catheter.  None  of  the  16  patients  had  urine  culture  positive  at  the  time  of  removal  and  so  they 
concluded that catheterization is the source of many UTI post transplantation and catheter tip culture 
would be a useful guide in the management.
90% of the bacteria isolated from patients with UTI  in post transplant period are gram negative 
bacilli, most common being E.coli21,22. The other species include Klebsiella, Proteus, Enterobacter and 
Pseudomonas23. Most of the infection occurring in outpatient was discovered by frequent routine urine 
analysis and culture  rather than by their symptoms. Most UTI are caused by single bacterial species. 
The isolation of three or more species in urine is usually contamination even when the colony count is 
high. A colony count threshold of  > 103cfu/ml should be used to diagnose complicated UTI except 
when urine cultures are obtained through a catheter, in which a level of  > 102cfu/ml is evidence of 
infection102. 
Urinary tract infections developing soon after transplantation are usually related to anatomical 
alteration resulting from surgery. Such early infections may require prolonged treatment. Urinary tract 
infections that occur more than 6 months after transplantation do not seem to be associated with the 
high rate of pyelonephritis or relapse seen with infections that occur in the first 3 months and may be 
treated for shorter periods.
In  preventing  UTI,  Trimethoprim  (80mg)  and  Sulfamethoxazole  (400mg)  may  be  used  as 
prophylaxis 1 tablet at bed time for the first 4-6 months with nystatin orally thrice daily to prevent 
Candida infection during the antimicrobial prophylaxis28.   
RESPIRATORY TRACT INFECTION          
Renal transplant patients have the respiratory infections that are common to normal persons and 
general hospital patients, but because of their defective cellular immunity, they also have infection by 
opportunistic organisms that in normal persons produce only trivial infection or not at all. Pneumonia is 
an  important  cause  of  morbidity and death  in  the  transplant  group30.  The  incidence  of  pulmonary 
infection  in  renal  transplant  recipients  has  declined  from  25%  to  8%  with  judicious  use  of 
immunosuppressive therapy and the aggressive treatment of infection31.
MAJOR CAUSES OF PULMONARY INFECTION30
BACTERIA : Pneumococcus
Staphylococcus
Gram negative bacteria
Legionella
Nocardia 
Mycobacteria   
FUNGI :  Aspergillus sp
Pneumocystis carinii
Candida sp
Mucor
Cryptococcus
VIRUSES : Cytomegalovirus
PARASITIC : Strongyloides stercoralis
Toxoplasma gondii
The  problem  of  identifying  the  causative  organism  in  lower  respiratory  tract  infection  is 
complicated  by  unreliability,  questionable  sensitivity  and  specificity  of  sputum  gram  stain  and 
cultures26,33.
Bronchoscopy with brush biopsy, bronchoalveolar lavage and transtracheal lung biopsy help in 
identifying the infective organisms in 90% of viral, 75% of P.carinii and 50% of Nocardial and fungal 
infections34.  In  open  lung  biopsy  the  diagnostic  yield  is  15%  of  the  autopsy  series  even  by  the 
pathologist  or  microbiologist  in  patients  with   pulmonary  infiltrates36.  Chest  x-ray alone  is  never 
diagnostic of any specific type of infection but it may give a clue as to the possible etiology and is 
helpful in assessing the progress of the disease and its response to therapy37.    
In a review of the spectrum of pulmonary infections in renal transplant  recipients in the tropics 
by Kalra  et al (2005)39,  40  renal transplant  recipients  reported with 44 episodes of pulmonary 
infections. Out of 44 episodes of  pulmonary  infection evaluated, single causative organism could be 
found  in  only  
24 (54.5%) episodes and multiple etiologies were found in 15 (34.1%) episodes. No definitive  cause 
could  be found  in  5  episodes. Out of 57 organisms isolated in the 44 episodes, 20 (45.4 %) were 
Bacteria, 16 (36.3 %) each  were  M. tuberculosis and Fungus, 3  were CMV  infection  and  2 were 
Nocardia. BAL gave a diagnostic yield of 75.8% (25 out of 33 cases). Nine of the forty patients died 
(mortality rate 22.5%) of which 6 deaths could be attributed directly to pulmonary infection. Out of 
these 9 patients who died, cause of pulmonary infection was Bacterial in 5, Fungal in 2 and  CMV 
disease in 1. In one patient, organism could not be isolated.
The incidence  of  active  tuberculosis  infection  in  renal  transplant  recipient  is  variable  from 
0.45% - 3.64%40.  Various forms of tuberculosis  have been noted from cavitating to military form. 
Infection by Mycobacterium tuberculosis and P.carinii are the most common nonpyogenic infections in 
the first year after transplantation in developing countries. An aggressive search for tubercle bacilli 
should be made using bronchoscopy and examination of BAL fluid in  patients not responding to a 
short trial of antibiotics. A four-drug regime without Rifampicin given for 18 months is effective for 
pulmonary tuberculosis in patients on cyclosporine. Routine prophylactic use of one single-strength 
tablet of Cotrimoxazole  daily for  at least six months after transplantation is recommended by Jha et 
al(1999)41.                          
GASTROINTESTINAL TRACT INFECTION
Gastrointestinal complications are frequent in renal transplant recipients and can include oral 
lesions, esophagitis, peptic ulcer, diarrhea, colon disorders and malignancy. Oral lesions may be caused 
by drugs such as Cyclosporine and Sirolimus,  by Virus or Fungal infections.  Candida and  Herpes 
simplex are the most common cause of Oesophagitis and stomatitis respectively in renal transplant 
recipients. Leukoplakia may develop in patients with Epstein-Barr virus (EBV) infection.
Candida is characterized by creamy white curd like patches on the tongue and on other mucosal surface, which are 
removable  by scraping and  leave  a  raw bleeding  and  painful  surface.  The  patch  is  a  pseudomembrane  consisting of 
Candida, desquamated epithelial cells, leukocytes, ulceration, necrotic tissues and food debris42. Candida oesophagitis was 
believed to occur by direct spread from oral candida, but reports have shown that approximately 30% of the patient with 
candida oesophagitis have no associated Oral Candida43. The most common symptoms of Candida oesophagitis include 
painful swallowing, a feeling of obstruction on swallowing, substernal chest pain, nausea and vomiting. Definitive diagnosis 
was made by brushing or biopsy during endoscopy44.
Gastroduodenal  ulcers  in  renal  transplant  recipients  are  usually  originated  from  excessive  acid  secretion  or 
infection of Helicobacter pylori. However in a study by Abu Farsakh et al(2001)45, prevalence of gastrointestinal symptoms 
due to  H.pylori and endoscopic and histological  findings in stable renal  transplant  recipients were  similar to those in 
controls.
Helminthic  infection  in  renal  transplant  recipient  is  not  rare  and  
hyper infestation with Strongyloides stercoralis has been noted46. Opportunistic infections with the nematode Strongyloides  
stercoralis occur most often in patients with impaired T lymphocyte function, including recipients of renal allografts. Occult 
intestinal  infection  can  remain  quiescent  for  more  than  30  years,  becoming  apparent  only  after  the  initiation  of 
immunosuppression. Pulmonary and gastrointestinal  symptoms predominant as initial  clinical  manifestations in patients 
with Strongyloides hyperinfection or dissemination47. The diagnosis is usually made by identifying the larvae in stools of 
the patient coming from a endemic area.                   
Cryptosporidium is a coccidian protozoan causing enteritis in immunocompromised individuals. Involvement of 
the intestine is patchy with small intestine being the most commonly affected site. It presents as watery diarrhoea,  crampy 
abdominal pain, weight loss, anorexia, flatulence and malaise. Incubation period for human cryptosporidiasis is between 2 
to 14 days. Faecal examination reveals cryptosporidium oocysts and mucus but no blood or leucocytes. Cryptosporidial 
oocysts are acid fast, which help in their differentiation from yeast. The infection is self limiting48.
Acute gastroenteritis in renal transplant recipients is caused by the same organisms seen in immunocompromised 
population.  Salmonella infection are also found involving the gastrointestinal  tract  in transplant  patients and they may 
require prolonged antibiotic therapy49.                         
CENTRAL  NERVOUS  SYSTEM  INFECTION
Infection of the central nervous system is an important cause of morbidity and mortality in the renal transplant 
recipient with a incidence of 7% with 50% mortality50. CNS infections in renal transplant recipients occur rather predictably 
between 1 and 12 months post transplant and are charaterised by a subacute onset and the frequent lack of systemic signs 30. 
Organisms associated with CNS infection in renal transplant recipients in descending order of frequency  are  Listeria,  
Cryptococcus, Mycobacteria, Aspergillus, Mucor, Toxoplasma and Strongyloides52. 
The finding of disorientation, confusion, memory loss or a decreased level  of consciousness in renal transplant 
recipient should lead to evaluation for a possible  CNS infection. Two important diagnostic procedures are CT scan of the 
brain and lumbar puncture. Listeria usually occurs both in the early and late post transplant period. Toxoplasma, Aspergillus  
and Nocardia infections usually occurs within four months post transplant. Mycobacterium tuberculosis and Cryptococcus 
infections occur exclusively beyond  four months post transplant.     
BACTEREMIA
Bacteremia  is  a  major  cause  of  death  in  renal  transplant  recipients.  The  major  cause  of  bacteremia  in  renal 
transplant recipient is Urinary tract infection with or without associated surgical complications. About 60 - 70% of the 
bacteremia in a study was found to have originated from the urinary tract53.  With better  approach to the treatment of 
infections, the incidence of bacteremias has decreased. Bowel perforation leading to gram negative bacteremia from the 
gastrointestinal tract is the other major cause54.
Bacteremic infections are a major cause of death among organ transplant recipients. Death at 14 days after onset of 
bacteremia was 11% in kidney recipients. Risk of death is associated with the severity of the underlying condition of the 
transplant  recipient, the source of the bacteremia,  and the microbial  agent.  Pseudomonas aeruginosa  and  Enterobacter 
species  had  fatality  rates  of  47%  
and 63%55.
After about one month post transplant, bacteremia without obvious evidence of septic foci or IV lines are most 
frequently due to  Listeria monocytogenes13.  The other organisms commonly isolated in bacteremic episodes are  Staph 
aureus, E.coli, P. aeruginosa and Candida. In a study by lin et al (2001)56, E.coli was the most common pathogen causing 
bacteremia (26.7%). Risk of death seemed higher if bacteremia occurred with a primary site of infection other than the 
urinary tract (26.7% vs  6.7 %) and after methyl prednisolone therapy.
SKIN AND SOFT TISSUE INFECTION
Skin infections among renal transplant recipients are very common and the spectrum of infections differs according 
to post transplant period57.
Vesicular skin eruptions in renal  transplant recipients are commonly due to  Varicella zoster (VZV) or Herpes  
simplex  (HSV) infection. Primary infection with HSV is rare in transplant patients. Reactivations are present, about 40% of 
which are asmptomatic.  Warell et  al  (1986)58 found that  47% of renal  transplant recipients excreted  HSV.  There is no 
evidence of transmission of the infection by the grafted kidney, nor does it cause graft dysfunction.
Symptomatic HSV infection usually presents with labial and oral lesions in the first month after transplantation 
Two  renal  transplant  recipients  have  been  observed  to  have  Eczema  herpeticum  (Koposis  varicelliform  eruption),  a 
disseminated skin infection with HSV usually developing at sites of previous skin injury.Both the patients recovered without 
visceral dissemination in association with decrease  in the level of  immunosuppression35.
Chickenpox  is  rare  in  graft  recipients,  but  zoster  occurs  annually  in  approximately  3%  of  renal  transplant 
patients,ten times the rate in normal people (Warrell et al., 1986 )58.  It may present as a typical localized dermatomal zoster, 
disseminated  VZV infection  or  unilateral  pain  without  skin  eruption,  associated  with  rise  in  specific  antibody  to 
Varicellazoster59.  Zoster eruption may be more severe and last longer in transplant recipients than the normal people. Hence 
the immune status of VZV in allograft recipients should be determined as a part of pretransplant work. The presence of VZV 
antibody  by  indirect  fluorescent  antibody  test  indicates  immunity.  Susceptible  patients  should  be  immunized  in  the 
pretransplant period with live attenuated vaccine. The vaccine appears to prevent clinical varicella following subsequent 
exposure. If  an immunocompromised patient with no history of chicken pox or vaccination and with no detectable VZ 
antibody has had contact with Zoster or Chickenpox, Zoster immunoglobulin should be given as soon as possible60.
Because of chronic immunosuppressive therapy, the skin of renal transplant recipients is considered more liable to 
fungal infections. In a study by Virgili et al (1999)61, Pityriasis versicolor (PV) was the most frequent dermatomycosis and 
showed a higher prevalence than in the normal population. In a study by Thambiah et al (1999)62, Dermatophytosis was 
detected  in  42% of 100 renal  transplant  recipients  screened,  of  whom 17% had  the  infection  for  more  than  1 year.  
Tinea cruris and tinea corporis were the  common  clinical  types observed. The commonest isolate was  Trichophyton 
rubrum.
Chronic  draining  ulcer  or  nodular  skin  lesions  should  always  raise  the  suspicion  of  atypical  mycobacterial 
infection63.  Musculoskeletal  infections  are caused  by a variety of  pathogens  in  renal  transplant  recipients.  Apart  from 
common  bacterial  organisms  like  Staphylococci,  Gram  negative  bacteria,
Mycobacterium tuberculosis, unusual organisms like atypical mycobacteria and fungi should be considered. 
MALARIA
Malaria should be considered in the differential  diagnosis  of fever in transplant  recipients who have received 
organs or blood products from an area of endemic malaria. Transfused blood is the presumed source of infection in the post 
transplant period. Mean incubation period is 12 days (7 – 29 days) for transfusion induced falciparum malaria. Falciparum 
malaria  can stay in blood for three years. Transmission via the renal allograft is unlikely in live relative donor transplant 
who are malaria free during the pre and post transplant period. In a study of tropical infections after renal transplantation 
from the National kidney Institute, Phillipines, 5 episodes of proven malaria occurred in 440 patients who had undergone 
renal transplantation. The patient mortality was 40% in this group64.
VIRAL HEPATITIS 
The most important  cause of Hepatitis in renal transplant recipients possibly is Non A Non B 
Hepatitis65,66.  Chronic  Liver  disease  is  one  of  the  most  important  complications  after  renal 
transplantation.  Hepatitis B  and Hepatitis C are the main causes of liver disease. Although there are 
controversial results, in some series,  Hepatitis B and Hepatitis C are associated with lower graft and 
patient survival. (Morelas et al, 2004)67. Despite the exclusion of patients with HBs Ag from organ 
and blood donation, the incidence of chronic liver disease after transplantation remained high, with 
abnormalities of liver function occurring in 7% to 24% of patients early in follow up and death due to 
liver failure in 8 % to 28% of the long term survivors of renal transplantation68.
The prevalence of HBV infection is higher in renal transplant recipients than in the general 
population,  and  HBV is  a  significant  cause  of  mortality  and morbidity after  renal  transplantation. 
(Emmet B. Keeffe, et al)69. Little clinical effects are seen in the early post transplantation period, but 
after two years, there is an increase in mortality in HBs Ag positive patients due to hepatic failure and 
intercurrent infection plays an important role in the mortality of these patients71. In a study by Behzad 
et  al  in Iran (2005)70, it  was concluded that neither HBV nor HCV infection appears to cause or 
contribute to renal dysfunction in the early period (1 year) after  renal transplantation. Nevertheless, a 
long-term consequence of chronic HBV or  HCV  liver disease or graft  loss  is  not  impossible in 
renal transplant recipients.
Transplantation of an organ from an HBV carrier is very  efficient means of transmitting the 
virus13.  The laboratory marker  is  the presence of  Hepatitis  B surface antigen.  This prevalence of 
illness is unfortunate, because acquisition of HBV during transplantation is associated with a markedly 
increased risk of  fulminant  hepatitis71.  More  problematic  is  the allograft  recipient  who already is 
chronically infected with  the virus.  Although virus  replication  often decreases  in  the  normal  host, 
immunosuppressive therapy appears to directly stimulate viral replication. This effect is reflected in a 
prompt increase in Hepatitis viral DNA polymerase activity, HBe Ag and Hepatitis B virus DNA as 
well as HBs Ag, that occurs shortly after initiation of immunosuppressive therapy.
Hepatitis C Virus, which accounts for virtually all cases of Non A Non B hepatitis in developed 
countries, is the major cause of hepatic and chronic liver disease in renal transplant recipients  and 
might also be related to the development of Hepatocellular carcinoma8. Anti HCV antibodies have 
been reported for 10 % to 40% of renal transplant recipients. Patients with ESRD  are at increased risk 
for  HCV  infection  because  of  their  continued  exposure  to  blood  and  blood  products,  horizontal 
transmission within hemodialysis units52.
The presence of HCV infection greatly influenced graft survival in renal transplant patients and 
a higher proportion of infected patients had renal and Hepatic dysfunction. A significant increase in 
fatal chest infections was noted in HCV positive patients (Mitwalli et al, 2005)72.
In  a  study  at  Miami  Veterans  Hospital,  Miami,  the  incidence  of  Anti  HCV  positivity 
pretransplant  was  30%.  At  one  year  post  transplant,  22%  tested  
Anti  HCV  positive.  22%  of  the  Anti  HCV  positive  patients  developed  significant  hepatitis  post 
transplant. No chronic liver disease has been noted in them. No difference in the patient and graft 
survival were noted between Anti HCV positive and Anti HCV negative patients73.
CYTOMEGALOVIRUS  INFECTION
Cytomegalovirus  (CMV) is  the most  important  viral  infection affecting Renal  transplant  recipients7.  In  normal 
people,  CMV  infection  uncommonly  produces  symptoms,  but  the  virus  subsequently  becomes  latent  in  monocytes, 
macrophages  and  polymorphonuclear  leukocytes  and tissues  such as  renal  tubules.  Cytomegaloviral  infection  in  renal 
allograft recipients is more often symptomatic and can be severe or even fatal30.
The infection is primary in a previously seronegative recipient. Primary infection occurs when the latently infected 
cells are transmitted from  seropositive donors to seronegative recipients. Approximately 60% of the seronegative patients 
become symptomatic with CMV disease74,75.
Secondary infection occurs in previously seropositive patients because of reactivation of the patient’s own latent 
virus or reinfection, but it is not possible to distinguish clinically between these two possibilties30. It is currently estimated 
that  approximately  20%  of  these  individuals  become  symptomatic  but   this  figure  is  strongly  influenced  by  the 
immunosuppressive therapy being administered. The titre of neutralizing antibody present in seropositive individuals does 
not predict the occurrence of symptomatic disease or the gravity of clinical disease it develops68.
Superinfection  occurred  when  seropositive  recipients  receive  an  allograft  from a  seropositive  donor  and  the 
reactivated virus is of donor rather than the recipient origin. The incidence of clinical disease in this group is probably 20% 
to 40% but again the incidence is modified by immunosuppressive therapy77,78.   The most important infectious disease 
effect by CMV infection, however is it’s broad based suppressive effect on host defences that can lead to opportunistic 
superinfection. Of particular interest is the linkage between CMV and Pneumocystis pneumonia8,76.
WOUND INFECTION
The incidence of wound infection varies from 1.8% to 56%. Unrelated cadaver kidneys, diabetes, urinary fistulas 
and wound  hematomas are all factors predisposing to wound infection.  If wound infections secondary to haematoma and 
urinary fistula are excluded, the incidence is 1.6% in the University of Minnesota.  If diabetics and retransplanted patients 
were excluded, the incidence of wound infection in non-diabetic patients who had their first transplant was only 0.7%, all 
being superficial79.
When deep wound infection is suspected it should be aggressively evaluated with ultrasonography and CT scan. 
Fine needle aspiration under ultrasonography or CT scan guidance may be very useful in confirming the diagnosis and 
detecting  the  aetiological  organism .The commonest  infecting organism is  either  coliform bacteria  or  Staphylococcus 
aureus. Others are less common (Cohen,2001)30.
Careful surgical technique and antibiotic prophylaxis can virtually eliminate  the potentially grave complication of 
wound infection in this high risk group of  patient80. Perioperative antibacterial administration  can decrease the rate of 
wound infection if it is above 4% without  prophylaxis81. Such therapy should be against uropathogens and Staphylococcus 
aureus. The most important factor in the prevention of wound sepsis is the technical quality of the surgery performed.
                                  MATERIALS AND METHODS
The  study  group  comprised   88  cases  of  renal  transplant  recipients, who underwent renal 
transplantation for end stage  renal  failure (ESRF)  at  Government General Hospital,  Chennai. It 
included two groups:
Group1 - 60 consecutive cases of renal transplantation performed on ESRF patients from Jan 2004 to 
Dec 2005 and including 59 live related donor kidney transplantation and 1 cadaver transplantation.
Group 2 -  28 renal  transplant  recipients  who were transplanted  before Jan 2004 and admitted for 
treatment during  Jan 2004 to Dec 2005.
All renal transplant recipients were screened pre operatively for the presence of any overt or occult infection by
a. Urine culture
b. Ear ,Nose, throat, axilla, umbilicus, groin and vascular access swab culture
c. Serological test for infection with  Hepatitis B, Hepatitis C, Cytomegalovirus  and  Human 
immunodeficiency virus.
d. X ray chest, ECG, Echocardiogram
e. HLA Typing of donor and recipient
POST OPERATIVE CARE
Immunosuppressive protocol consisted of administration of  Triple drug regime - Cyclosporine, 
Azathioprine and Prednisolone. Rejection episodes were treated with Intravenous Methylprednisolone, 
Intravenous Dexamethasone or Oral Prednisolone or OKT3.      
Urine specimen were collected daily for analysis and cultured for the first two weeks. Drain 
fluid and tips of foley catheters were collected and  cultured. Whenever infections occurred , samples 
were collected accordingly.
Patients  were  immunized  against Hepatitis  B  whenever  possible.
The transplant protocol followed at Government General Hospital,Chennai is as follows
- ESRF patients with voluntary living related donor are accepted for renal transplantation.
- Second degree relatives are accepted only if there  were no suitable first degree donor 
available.
-  Cadaver transplant
- All recipients receive a minimum of 3 units of non specific blood transfusion.
- All  patients  were  started  on  Triple  drug  regime  -  Cyclosporine,  Azathioprine  and 
Prednisolone.
- Details  of  pre  transplant,  intraoperative  and  post  transplant  events  were  carefully 
recorded.
- Recipients  discharged from the hospital on 14th  post operative day unless delayed by 
complications. Outpatient follow up done at  weekly intervals for months and at two 
weekly intervals thereafter and more frequently if required.             
All patients were put on Oral Cotrimoxazole prophylaxis for three months post transplant and 
Nystatin mouth wash.
Bacterial,  Fungal,  Viral  and  Parasite  studies  were  carried  out  on  the  specimens  whenever 
required.
METHODOLOGY
A. Collection of specimen
B. Macroscopical examination
C. Microscopical examination
D. Culture procedure and identification of organisms
E. Antibiogram
F. Detection of Extended spectrum beta lactamase (ESBL) production.
G. Plasmid DNA isolation for Gram negative bacteria that were resistant to   Third generation 
cephalosporins.
A. COLLECTION OF SPECIMENS
Urine, Drain fluid, foley catheter tip and Drain tip were collected from all cases. According to 
signs and symptoms, Blood, Serum, Sputum, Oral scrapings, Faeces, Pus and CSF were collected.
1. Urinary tract
(a) Urine 
1. Urine from the catheterized individuals were collected in a sterile     universal container.
2. Clean catch mid stream urine were collected in a sterile wide mouthed bottle  after thorough 
preliminary cleaning of external genitalia with soap and water.
(b) Catheter tips - were put in glucose broth. 
2. Respiratory system
(a) Sputum - patients were instructed to have mouth wash and gargle with sterile distilled 
water  and  to  cough  when  the  sputum  was  felt  in  the  throat  /  mouth.  Patient  was 
instructed to collect it directly into a sterile container at one time.
(b) Bronchoalveolar  lavage  -  Under  sterile  precautions,  bronchoalveoalar  lavage  was  done  and  sample 
collected in two sterile tubes. 
(c) Pleural fluid - under sterile precautions, the aspirated pleural fluid was collected in a 
sterile tube.
3. Gastrointestinal tract
(a) Oral scraping - The lesions were scraped with sterile swab.
(b) Upper gastrointestinal brushing - were collected in a sterile test tube.
(c) Gastric aspirate - Gastric aspiration was done and the sample was collected in a sterile 
tube.
(d) Faeces - the specimens were collected in a sterile 25 ml wide mouthed  bottles.  
4. Central nervous system
Cerebrospinal fluid - Under sterile  aseptic condition, lumbar puncture was done and the CSF 
was collected in a sterile test tube.
5. Skin and soft tissue
(a) Wound swab - using sterile swab, the specimen’s were collected.
(b) Pus - using sterile swab or sterile syringe the specimen’s were collected in sterile tubes.
(c) Tissue biopsy - under sterile aseptic condition, the tissue biopsy was taken and collected 
in sterile tubes.
6. Drain
(a) Drain fluid were collected in a sterile test tube.
(b) Drain tips were put in glucose broth.
7. Bacteremia
(a) Blood - Under sterile aseptic conditions, 5 ml of blood was taken intravenously and 
inoculated into Brain heart infusion broth immediately.
(b) Serum  -  Serum  samples  were  collected  in  sterile  test  tubes   for  Widal  test  and 
Microscopic agglutination test (MAT).
8. Malaria – Peripheral blood samples on clean glass slides were taken.
9. Hepatitis B, Hepatitis C and Cytomegalovirus -  serum samples were collected in a sterile test 
tube.
The Samples were transported to the laboratory immediately without any delay and processed.
B. MACROSCOPIC EXAMINATION
1. Urine - observed for turbidity and color
2. Sputum - Examined for color (red, Brown, Yellow, Green or Whitish), Consistency - 
thick or thin sputum, Presence of mucous, mucopurulent and frothy material (saliva) and 
any other abnormal looking material.
3. Bronchoalveolar lavage - observed for blood and abnormal materials.
4. Cerebrospinal  fluid  -  Examined  for  turbidity,  contamination  with  blood  (from  the 
puncture site) and color.
5. Faeces  -  Looked  for  consistency,  presence  of  mucous,  pus,  blood  and  presence  of 
parasites.
C. MICROSCOPICAL  EXAMINATION 
(a) Urine (1)  Wet  preparation  -   examined  for  the  presence  of  pus  cells,  
red cells, yeast cells and bacteria.
(2) Gram stain - smear was prepared, air dried and fixed. Stained by Grams method and examined 
under oil immersion and looked for gram positive and gram negative bacteria.
(b) Sputum  (1) Wet preparation - the sputum was mixed with a drop of saline, looked for cells and 
yeast like organisms.
(2)  KOH mount- The sputum was emulsified with few drops of 10 % KOH kept for 5 minutes and 
examined under low and high power objective for the presence of branching and unbranching fungal 
elements.
(3) Stained preparation 
Gram stain – smear was prepared, air dried  and fixed. Stained by grams method and examined 
under oil immersion  and observed for the presence of squamous, epithelial cells, cellular infiltrates - 
polymorphonuclear leukocytes, mononuclear leucocytes, gram positive and gram negative bacteria.
Ziehl - Neelson technique - smears were stained by Ziehl - Neelson technique and examined for 
acid fast bacilli.
(c) Bronchoalveolar lavage (1) Direct wet preparation and KOH mount was done, under the low and 
high  power  objective,  looked  for  the  presence  of  pus  cells,  mononuclear  cells,  ciliated  columnar 
epithelial  cells, yeast like organisms and fungal elements. 
(2) Stained  preparation - Two smears were air dried and fixed.
- One smear was stained by gram’s technique and examined for             cells, bacteria and 
fungi.
- Second smear was stained by Ziehl – Neelson  technique and examined for acid fast bacilli.
(d) Pleural fluid - Two smears were prepared - one for gram’s stain and one          for Ziehl – Neelson 
technique and examined.
(e) Gastric lavage -  Smear prepared by Ziehl – Neelson technique was examined for acid fast bacilli.
(f) Faeces - examined for the parasites by saline and iodine mount.
(g) Cerebrospinal fluid - Two smears were made air dried and fixed, Gram stain and Ziehl Neelson 
stain were done and observed under oil immersion.
Negative staining – India Ink preparation – one drop of CSF was placed on a clean glass slide 
and mixed with a drop of India ink and a cover slip was placed, examined under low and high objective 
for the organisms. Staining by Nigrosin method was also done.
(h) Malarial parasites - Thick and thin blood smear was prepared, stained by Leishman’s stain and 
examined for malarial parasites.      
CULTURE MEDIA USED
Specimen Media used
Enrichment Bacterial culture Fungal culture
Urine   - CLED SDA
Catheter tips Glucose broth S/
C, after  24 hrs
MAC,BAP SDA
Sputum MAC,BAP,CAP,LJ SDA
Broncho alveolar Lavage MAC,BAP,LJ SDA
Pleural fluid MAC,BAP,LJ SDA
Oral scraping - - SDA
Oesophageal brushing - - SDA
Gastric lavage - LJ -
Faeces Selenite broth S/
C after 6hrs
MAC
BAP
-
Wound swab/Pus MAC
BAP
SDA
Tissue biopsy Glucose broth
S/C after 24 hrs 
SD broth 
S/C after 24 hrs
MAC
BAP
LJ
SDA
CSF MAC,BAP,CAP SDA
BAP - Blood agar plate MAC - Mac conkey agar
LJ - Lowenstein Jensen medium SDA - Sabouraud’s  Dextrose Agar
CLED - Cystine Lactose Electrolyte CAP -  Chocolate agar
Deficient Medium
D. CULTURE PROCEDURE AND ISOLATION OF ORGANISMS.
The specimens were inoculated into their respective media immediately without delay.
(a) Incubation of inoculated media -
MAC, BAP and CLED plates were incubated aerobically at 370C. Chocolate agar plates was 
incubated in a candle jar at 370C.
LJ slopes - one was inoculated at room temperature and other in the incubator at 370C.
Sabourauds dextrose agar slant’s - one incubated at 370C aerobically and another one incubated 
aerobically at 250C.
(b) Examination of inoculated media
After 24 hrs incubation
MAC, BAP, Chocolate  agar,  CLED plates  were examined after  24 hrs  for the presence of 
growth. If growth was seen, the degree of growth was noted as profuse, moderate or scanty. 
Preliminary identification of organism was made by colony morphology using hand lens. In 
case of mixed growth, the relative degree of growth of each species was noted. The growth was 
subjected to Grams stain, Hanging drop for motility and biochemical reactions for identification 
of the organism. If no growth occurred or no colony suggestive of possible pathogens were 
seen., the plates were reincubated for another 24 hrs.
For urine culture - inoculation was done by using a standard bacteriological loop. Colony count 
of > 103 indicates significant bacteriuria.
After  48 hrs  incubation,  MAC, BAP, Chocolate  agar,  CLED plates  were examined for  the 
presence of growth. The growth was subjected to Gram’s stain, Hanging drop for motility and 
biochemical reactions for identification of organism.
If no growth was seen, plates were discarded and reported as no growth. 
LJ media were examined daily for the first 5 days and then at  weekly intervals for upto 3 
months.
The  Sabouraud’s  dextrose  agar  slants   were  observed  for  the  presence  of  growth  daily.  If 
positive  for  growth,  smear  was  prepared  and  stained  by  
Gram’s stain, Lactophenol cotton blue mount was done and examined. If yeast cells were seen, germ 
tube test was done to differentiate  Candida albicans from the other Candida species. If  no growth was 
present, the SDA  slants were reincubated further and examined  on  3rd, 5th, 7th, 10th, 14th, 21st days 
and one month. If no growth was seen after one month, then the SDA slants were discarded. CHROM 
agar medium was inoculated for speciation of Candida.
Serological tests - Widal test for Enteric fever.
MAT  for Leptospirosis 
Hepatitis B, Hepatitis C, Cytomegalovirus - The serum samples  were screened for the presence 
of Hepatitis B surface antigen, Anti HCV antibody (Microlisa Kit, J. Mitra) and  CMV  IgM  by ELISA 
(Lilac kit) technique.
E. ANTIBIOGRAM
Antibiotic susceptibility testing of the bacterial isolates were done by Disc diffusion technique 
using Mueller Hinton agar plates and the susceptibility or resistance of the isolates were noted by Kirby 
Bauer chart and recorded. The antibiotics used for  Antibiotic susceptibility testing were Penicillin, 
Erythromycin,  Ampicillin,  Cefotaxime,  Ofloxacin,  Co trimoxazole,   Oxacillin  and Vancomycin for 
gram positive bacteria.
Gram negative  bacteria  were tested  with Gentamycin,  Ofloxacin,  Cefuroxime,  Ceftazidime, 
Cefaperazone, Ampicillin, Co trimoxazole and Imipenem.  
F. DETECTION OF ESBL PRODUCTION
Gram negative bacilli that was resistant to ceftazidime was tested for Extended spectrum beta 
lactamase production. ESBL production was tested with ceftazidime and amoxyclav discs. Extension of 
amoxyclav zone towards ceftazidime was taken as positive for ESBL production.
MIC for Ceftazidime was put as per NCCLS standards for the Gram negative isolates that were 
resistant to Third generation cephalosporin Ceftazidime.
G. PLASMID DNA ISOLATION
Plasmid DNA isolation was done for Ceftazidime resistant Gram negative bacteria.
                                                     RESULTS
Total Number of patients - 88
TABLE – 1
Group 1 60 renal transplant recipients during Jan 2004 to Dec 2005
Group 2 28  renal transplant recipients, transplanted before Jan 2004 and 
admitted for treatment during Jan 2004 to Dec 2005
                                                     
TABLE 2
Age and Sex distribution
Age Sex
Male Female
10-20 14 10
21-30 33 6
31-40 20 2
41-50 2 -
51-60 1 -
Total 70 (79.55%) 18(20.45%)
Predominant Age group was between 21 - 40 yrs and 80% were males.
DONOR STATUS
Live Donor Transplantation - 87
Cadaver transplantation - 1
Sex distribution in relation to infections.
TABLE 3
No. of patient Male Female
70 18
Total  no. of  infections (n=246) 189 57
% 76.8 23.2
Higher incidence of infection occurred in Male patients.
Prevalence of infection in renal transplant recipients
TABLE 4
Infections No. of Infections 
(n = 246)
Urinary tract infection 130 52.8%
Respiratory tract infection 27 10.3%
Drain infection 23 9.3%
Gastrointestinal tract infection 17 6.9%
Bacteremia 11 4.4%
Skin and soft tissue infection 10 4%
Cytomegalovirus 8 3.2%
Wound infection 6 2.4%
Hepatitis C 5 2.03%
Malaria 4 1.6%
Hepatitis B 4 1.6%
Central nervous system infection 1 0.4%
Urinary  tract  infections  were  common  followed  by  Respiratory tract infections.
Isolation  of  organisms  in  relation  to  the  infection  involved
TABLE - 5
Infections Bacteria Fungus Virus Parasite Total
(n = 246)
Urinary tract infection 114 16 - - 130
Respiratory tract infection 22 5 - - 27
Drain infection 19 4 - - 23
GIT  infection - 12 - 5 17
Bacteremia 11 - - - 11
Skin and soft tissue infection 6 4 - - 10
Hepatitis B & C - - 9 - 9
CMV infection - - 8 - 8
Wound infection 5 1 - - 6
Malarial infection - - - 4         4
CNS infection - 1 - - 1
177 43 17 9 246
Bacterial infections were the most common infections in the post transplant period.
URINARY TRACT INFECTIONS
Total no. of infections : 130
Total no.of patients : 60  
Multiple episodes of infection - 45 patients
Single episode of infection - 15 patients
Sex distribution                                 
TABLE - 6
No. of  Patient Male Female
48 12
Total no. of infection 98 32
% 75.3 24.7
Increased incidence of urinary tract infections were noted in Males.
Organisms isolated (n=130)        
TABLE - 7
Bacteria – 114   ( 87.6%) Fungus -16   (12.4%)
E.coli 45 39.4%
Klebsiella pneumoniae 24 21%
Pseudomonas aeruginosa 23 20.1%
Proteus mirabilis 10 8.7%
Staph aureus 4 3.5%
Klebsiella oxytoca 4 3.5%
Acinetobacter baumanii 2 1.7%
Enterococci 2 1.7%
Candida albicans       - 13 (81.2%)
Candida  krusei          -   2 (12.5%)
                
Candida tropicalis      -   1  ( 6.2%)
Commonest organism causing UTI  was E.coli (39.4%)
Isolation of organisms in relation to duration of post transplant period
TABLE – 8
Month Bacteria Fungus Total
0 – 1 86 6 92
2 – 3 12 8 20
4 – 6 5 0 5
7 – 12 2 0 2
> 12 9 2 11
More number of bacterial infections occurred during 1st month post transplant
RESPIRATORY SYSTEM (RTI)
Total no. of infections = 27
Total no of patients = 22
Sex Distribution
TABLE-9
No. of  Patients
Male Female
20 2
Total no. of infection 24 3
                  % 88.8 11.2
Higher incidence of RTI occured in Males.
Organisms isolated (n=27)
TABLE -10
Bacteria -22  (81.4%) Fungus - 5 (18.6%)
Klebsiella  pneumoniae 10 Aspergillus flavus 2
M. tuberculosis 6 Candida albicans 1
Pseudomonas aeruginosa 4 Aspergillus fumigatus 1
Staph. aureus 2 Mucor 1
Isolation of Organisms in relation to post transplant period.
TABLE - 11
Month Mycobacteria Other Bacteria Fungus
0 – 1 0 1 0
2 – 3 0 2 0
4 – 6 4 6 1
7 – 12 2 3 2
> 12 0             4 2
Bacterial infections were common during the first one year post transplant period.
DRAIN  INFECTIONS
Total no. of infections - 23
Organisms isolated (n=23)
TABLE -12
Bacteria – 19 (82.6%) Fungus – 4(17.3%)
Pseudomonas aeruginosa 8
E.coli 4
Staph aureus 3
Klebsiella pneumoniae 3
Micrococci 1
Candida albicans - 4
Pseudomonas aeruginosa was the predominant organism causing drain infection.
GASTROINTESTINAL TRACT INFECTION (GIT)
Total no. of infections – 17
Organisms isolated (n=17) 
TABLE – 13
Fungus -12 (70.5%) Parasite- 5 (29.5%)
Candida  albicans 
 Candida  tropicalis
 Candida  glabrata
    10
      1
      1
E. h cyst
A. duodenale
S. stercoralis
     3
     1
     1
Isolation of Organisms in relation to post transplant period
TABLE – 14
Months Fungus Parasite
0 -1 2 0
2 -3 2 3
4 -6 4 1
7 - 12 1 0
> 12 3 1
Most  of  the GIT  infections occurred during 2 – 4 months post transplant.
Candidiasis
                                             TABLE – 15
Oral candidiasis 5
Oesophageal candidiasis 3
Oral and  Oesophageal candidiasis 2+2
Candida albicans was the common organism causing GIT  infection.
BACTEREMIA
Total no. of bacteremia – 11
TABLE – 16
Organisms No. of 
infection
Klebsiella  pnuemoniae 4
Pseudomonas aeruginosa 2
E. coli 2
Acinetobacter baumanii 1
Staph aureus 1
Leptospira icterohaemorrhagia 1
Klebsiella pnuemoniae was the most common organism causing Bacteremia.
SKIN  AND  SOFT  TISSUE  INFECTION
Total no. of infections – 10
Organisms isolated 
TABLE - 17
Bacteria  6 (60%) Fungus 4 (40%)
Staph aureus
E. coli
Pseudomonas  aeruginosa
M.tuberculosis
2 
2
1
1
Trichophyton  rubrum
Trichophyton  mentagrophytes
Aspergillus flavus
2
1
1
CYTOMEGALOVIRUS  INFECTION
Total no of  CMV  positive  -  8
Before 12 months - 5     
After 12 months    - 3
CMV infection occurred more commonly within one year post transplant period.
VIRAL HEPATITIS
TABLE – 18
Virus No of infections
n=9
Hepatitis C 5
Hepatitis B 4
Hepatitis  C
   No. of  Hepatitis  C  positive      -  5
                                             TABLE - 19
Month No. of infections
0 – 1 yr 1
> 1 yr 4
   
Hepatitis B
No. of  Hepatitis  B  positive     -  4
TABLE  - 20
Month No. of infections
0 – 1 -
2 – 3 -
4 – 6 1
7 – 12 1
> 12 2
Hepatitis B and  C occurred  more commonly after 1 year post transplant.
WOUND INFECTION
Total no. of infection – 6
Organisms isolated
TABLE – 21
Bacterial  (5) Fungus (1)
Klebsiella  pneumoniae 2
E. coli 2
Staph aureus 1
Candida albicans - 1
Wound infections caused by bacteria occurred more commonly in the first month post transplant period.
Malaria
No. of  infection  -  4
Plasmodium falciparum   - 2
Plasmodium vivax            - 2
CENTRAL NERVOUS SYSTEM INFECTION
Cryptococcus neoformans – 1 
(isolated  in the 9th month post transplant period )
ISOLATION OF ORGANISMS IN RELATION TO DURATION OF POST TRANSPLANT 
PERIOD
TABLE - 22
Months Bacteria Mycobacteria Fungus Virus Parasite
0 - 1 113 0 13 0 2
2 – 3 19 0 10 0 3
4 -6 14 4 5 4 2
7 - 12 7 2 7 5 1
> 12 17 1 8 8 1
SYSTEM WISE   ISOLATION  OF  ORGANISMS  IN  RELATION  TO POST  TRANSPLANT DURATION.
TABLE - 23
Months UTI RTI Drain GIT Bacteremia Skin/soft 
tissue
CMV Hepatitis Wound Malaria CNS
0 -1 92 1 23 2 1 1 - - 6 2 -
2– 3 20 2 - 5 3 2 - - - - -
4– 6 5 11 - 5 2 1 2 2 - 1 -
7- 12 2 7 - 1 2 3 3 2 - 1 1
> 12 11 6 - 4 3 3 3 5 - - -
MORTALITY 
TABLE – 24
No. of patients Mortality
88 10
Out of 10 deaths, 4 were  due to Bacteremia ( 40%).
Mortality was more commonly due to Gram negative bacteria.
ANTIBIOGRAM
ANTIBIOTIC SENSITIVITY FOR GRAM POSITIVE ORGANISMS
TABLE - 25
Organism Pen
%
Ery
%
Oxa
%
Oflox
%
Ampi
%
Co-tri
%
Cefotax
%
Vanco
%
Staph aureus             (13) 1
(7.6)
10
(76.9)
11
(84.6)
9
(69.2)
6
(46.1)
3
(37.5)
8
(61.5)
13
(100)
Enterococci faecalis  ( 2) 0 1
(50)
0 0 1
(50)
0 0 2
(100)
Micrococci                ( 1) 0 1
(100)
0 1
(100)
0 0 0 1
(100)
Gram positive organisms showed Highest sensitivity to Vancomycin followed by Erythromycin.
2 Oxacillin resistant  Staph aureus ( MRSA)   were sensitive to Vancomycin.
ANTIBIOTIC SENSITIVITY  FOR GRAM  NEGATIVE  ORGANISMS 
TABLE 26
Organism Oflox
%
Genta
%
Ampi
%
Co- tri
%
Cefurox
%
Ceftaz
%
Cefaper
%
Imi
%
E.coli (53) 49
  (92)
21
(39.6)
42
(79.2)
38
(71.6)
30
(56.6)
51
(96.2)
51
(96.2)
53
(100)
Klebsiella  sp
             
(47) 39
(82.9)
40
(85.1)
4
(8.5)
31
(81.5)
40
(85.1)
47
(100)
47
(100)
47
(100)
Pseudomonas 
aeruginosa 
  
(38) 10
(26.3)
24
(63.1)
4
(10.5)
6
(15.7)
0 25
(65.7)
25
(65.7)
38
(100)
Proteus 
mirabilis     
(10) 10
(100)
8
(80)
10
(100)
2
(20)
4
(40)
10
(100)
10
(100)
10
(100)
Acinetobacter  
 baumanii  
(3) 3
(100)
3
(100)
1
(33.3)
1
(33.3)
0 3
(100)
3
(100)
3
(100)
                  
  
No. of Organisms resistant to Ceftazidime : 15  (2 E.coli & 13 Pseudomonas 
aeruginosa)
No. of  ESBL  producers :  11(2  E.coli & 9 Pseudomonas 
aeruginosa)
Plasmid   Isolation:   Plasmid was isolated in 8 Pseudomonas aeruginosa isolates
ISOLATION OF ORGANISMS IN RELATION TO THE SITE OF INFECTION
TABLE - 27
ORGANISMS Urine Sputum/ BAL/
Pleural fluid
Drain Blood Skin/
Soft tissue
Wound Oral scraping / Faeces/ 
Gastric aspirate
CSF
BACTERIA
E.coli 45 - 4 2 2 2 - -
Klebsiella pneumoniae 24 10 3 4 - 2 - -
Pseudomonas aeruginosa 23 4 8 2 1 - - -
Proteus mirabilis 10 - 3 - - - - -
Staph aureus 4 2 - 1 2 1 - -
Klebsiella oxytoca 4 - - - - - - -
Acinetobacter baumanii 2 - - 1 - - - -
Enterococci 2 - - - - - - -
Micrococci - - 1 - - - - -
M.tuberculosis - 6 - - 1 - - -
Leptospira icterohaemorrhagiae - - - 1 - - - -
FUNGI
Candida albicans 13 1 4 - - 1 10 -
Candida species 3 - - - - - 2 -
Aspergillus fumigatus - 1 - - - - - -
Aspergillus flavus - 2 - - 1 - - -
Mucor - 1 - - - - - -
T.rubrum - - - - 2 - - -
T.mentagrophytes - - - - 1 - - -
Cryptococcus - - - - - - - 1
VIRUS - - - - - - - -
CMV - - - 8 - - - -
Hepatitis B - - - 4 - - - -
Hepatitis C - - - 5 - - - -
PARASITE
Plasmodium falciparum & vivax - - - 4 - - - -
E.h cyst - - - - - - 3 -
A.duodenale - - - - - - 1 -
S,stercoralis - - - - - - 1 -
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                                         DISCUSSION
Successful  renal  transplantation  is  today’s  best  chance  for  rehabilitating 
individuals with end stage renal disease. To achieve this goal, prevention and treatment 
of infectious disease complications of transplantation are of major importance and the 
requisite immunosuppressive therapy must be judiciously administered (Rubin,1993)9.
Eighty eight renal transplant recipients were included in the present study. It 
comprised of 60 consecutive renal transplant recipients, transplanted during Jan 2004 to 
Dec 2005 and 28 renal transplant recipients, transplanted before Jan 2004  and admitted 
for infection during Jan 2004 to Dec 2005 (Table 1).
The  study group comprised  of  79.5% male  recipients  and  20.5% of  female 
recipients,  male  to  female  ratio  being  3.8:1  (Table  2).  In  a  study  by  Ravikumar 
(1992)83,  there was a predominance of male population (82.5%) and male to female 
ratio of 4.7:1 during July 1987 to 1992. The predominant age group in this study was 
between 21 - 40 yrs (Table 2).
87 cases underwent Live donor transplantation and 1 case underwent Cadaver 
transplantation.
Total number of infectious episodes in this study were 246 (Table 3).
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Urinary  tract  infections  were  common  followed  by  Respiratory  tract
infections (Table 4).
Bacterial infections were the most common infections in the post transplant period (Table 5).
URINARY TRACT INFECTION
Urinary tract  infections were the single most common infection occurring in 
renal transplant recipients, as noted in the present study and also reported by Rubin et 
al (1981)13 and Desai JD.S., Jadav et al (1992)84. Urinary tract infection constituted 
52.8% (Table 4) of  the total infectious episodes in the study. Desai JD.S., Jadav et al 
(1992)84 observed the incidence of 53% in their  study,  which coincides  with  this 
study.  In  studies  carried  out  by Hinmanf  (1969)17,  Leigh  D.A.(1970)18,  Chan PC 
(1990)88  the reported incidence varies from 30- 79%. The incidence was found to be 
51% by  Ravi  kumar(1998)83 in  the  study done  in  Government  General  Hospital, 
Chennai. 68% of the patients developed one or more urinary tract infections in this 
study as compared to 43% in a study by Chuang et al (2005)86.
45 patients (75%) had multiple episodes of infections  and 15 patients( 25%) 
had  single  episode  of  urinary  tract  infection.  Mroz  et  al(1993)85 observed  similar 
results in his study. Ravi kumar (1998)83 had a higher rate of single infections (60%) 
in his study. Increased incidence of urinary tract infections were noted in Males.
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The aetiological agents causing urinary tract infection in the present study were 
Bacteria (87.6%) and Fungi (12.4%) (Table 7). The bacterial  isolates included E.coli,  
Klebsiella  pneumoniae,  Klebsiella  oxytoca,  Pseudomonas  aeruginosa,  
Proteus  mirabilis,  Staph aureus,  Acinetobacter  baumanii  and  Enterococcus  faecalis 
(Table 7). Similar organisms were also isolated by Paul D. Ellner  (1987)23.  E.coli 
(39.4%) followed by Klebsiella pneumoniae (24.5%) were the most frequently isolated 
organism in this  study.  Takai  et  al  (1998)29 found that  E.coli was  the commonest 
organism causing urinary tract infection. Gram negative bacilli of Enterobacteriaceae 
family  were  most  frequently  isolated  in  urinary  tract  infections  in  a  study  by  
Morz E et al (1993)85.
12.45% of the urinary tract infections were due to fungi of which  81.25% was 
due to  Candida albicans, 12.5% were due to  Candida krusei and 6.2% were due to 
Candida tropicalis.  87.5% of the urinary tract infections caused by Candida occurred 
within 6 months of renal transplantation(Table 8) as compared to 61.7% in a study by 
Moyses et al(1997)96. Funguria has been attributed in part to the widespread use of 
broad spectrum antibiotics, Corticosteroid, antineoplastic agents, immunosuppressive 
agents and urinary catheterization.
In the present study it was noted from the incidence of urinary tract infection in 
relation to post transplant duration, there was a decline in urinary tract infection after 
one month post transplant(Table 8). Mroz et al(1993)85 and  Ravi kumar (1998)83 also 
observed the same in their study. The increased incidence of Urinary tract infections in 
the first month after transplant could be attributed partly to post surgical complications 
and partly due to immunosuppression.
59
RESPIRATORY TRACT INFECTION
Respiratory  tract  infection  constituted  about  10.3%  of  the  total  infectious 
episodes  in  the current  study (Table 4).  The  reported  incidence varies  from 8% as 
observed by Moore F.D et al (1983)31, 15% by Giri (1992)82 and 12.6% by  Ravi 
kumar (1998)83. The causative organisms were more commonly Bacterial (81.4%) and 
Fungal  infections constituted 18.6% (Table 10).
Higher incidence of Respiratory tract infections were noted in males.(Table 9). 
Organisms  causing  bacterial  infection  were  Klebsiella  pneumoniae  (45.4%), 
Mycobacterium  tuberculosis  (27%), Pseudomonas  aeruginosa  (18%  )  and  Staph 
aureus  constituted 9% of  the bacterial infections. Similar organisms were isolated in 
other studies by Desai JD.S Jadav et al (1993)84 and  Ravi kumar (1998)83. 
Mycobacterium  tuberculosis was  isolated  in  6  patients.  Three  were  isolated  from 
sputum, two were isolated from Bronchoalveolar  lavage fluid and one was isolated 
from pleural fluid. The incidence of  Mycobacterium  tuberculosis was 27% among 
respiratory tract infections as compared with 37% in a study by Jha et al (1999)41. 
Most of the cases of  M.tuberculosis occurred within one year post transplant (Table 
11).  
Gee-Chen  Chang(2004)87 also  reported  pulmonary infections  within  one  year  post 
transplant. In a study by Lattes et al (1999)40, median time of onset of Tuberculosis 
was 13 months after renal transplantation.
Fungal infections constituted 18.6% of the total respiratory tract infections. The 
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incidence  of  0-14%  fungal  infection  was  reported  by  Paya  CV(  1993)92 and  
Dummer  et  al  (1983)93.  The  fungi  isolated  in  this  study were  Aspergillus  flavus,  
Candida albicans, Aspergillus fumigatus and Mucor (Table 10).  Ravi kumar(1998)83 
observed  Aspergillus flavus  and  Candida albicans as  the fungi causing respiratory 
tract infections in his study.
DRAIN INFECTION
Total number of  drain  infections  was 23 (9.3%) (Table 4). Bacterial isolates were 19 and 
fungal  isolates  -  4.  The  Bacterial  isolates  included  
Pseudomonas aeruginosa  (8), E.coli  (4), Staph aureus (3),  Klebsiella pneumoniae  (3) and Micrococci  
(1). Pseudomonas aeruginosa was the predominant organism causing drain infection. The fungal isolates 
were Candida albicans (Table 12). Similar results were obtained by Ravi kumar in his study (1998)83.
GASTROINTESTINAL TRACT INFECTION
Infections of the Gastrointestinal tract occurred in 6.9% of the total infectious 
episodes.  Incidence  of  5%  was  noted  by  Giri  (1992)82.  The  causative  organisms 
isolated  were  Fungi  (70.5%)  and  parasites  (29.5%)  (Table  13).  Candida  albicans,
Candida tropicalis and Candida glabrata were the fungi isolated. 
E.h.  cyst,  Ankylostoma  duodenale  and  Strongyloides  stercoralis were  the 
parasites found in the present study (Table 14). Strongyloides stercoralis was isolated 
in  a patient who had a cadaver  transplant.  Majority of the GIT infections occurred 
between 2 – 6 months post transplant duration. Oral candidiasis was found in 43.75 % 
of the gastrointestinal tract infection in this study (Table 15) which correlated with 44% 
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observed in a study by Giri(1992)82.
BACTEREMIA
11episodes   of   bacteremia   were  noted  in   this   study  with  organisms 
identified  being  Klebsiella  pneumoniae-4,  Pseudomonas aeruginosa -  2 ,E.coli-  2, 
Acinetobacter  baumanii-1,  Staph  aureus  -1 and  Leptospira  icterohaemorrhagia-1
( Table 16).  Out of 88 patients,  12.5 % developed Bacteremia in the present study 
compared with 11.5% of bacteremia observed by Moreno A (1994)98 in his  study. 
Klebsiella pneumoniae were the commonest organism identified in the present study, 
but Lin et al(2001)56 reported E.coli being the commonest isolate.
SKIN AND SOFT TISSUE INFECTION
Skin  and  soft  tissue  infection  accounted  for  4% of  the  infectious  episodes  
(Table  4).  Among  the  6  bacterial  infections,  Staph  aureus-2,  E.coli-2  and 
Pseudomonas aeruginosa-1 were isolated. Mycobacterium tuberculosis was isolated in 
one patient with lymphadenitis.  Among the Fungal infections,  Trichophyton rubrum 
was the commonest isolate (Table 17). Similar results was  observed in a study by 
Thambiah et al (1999)62. Other fungi isolated were Trichophyton mentagrophytes and 
Aspergillus flavus.
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CYTOMEGALOVIRAL INFECTION
Cytomegalovirus infection is a recognized problem of the early post transplant 
period in renal transplant recipients (Boehter A, 1994)99. In the present study, eight 
patients  (3.2%)  developed  cytomegalovirus  infection-5  patients  developed  CMV 
infection within 12 months of transplantation and 3 patients developed CMV infection 
after one year post transplant (Table 23).
VIRAL  HEPATITIS
HEPATITIS C
Hepatitis C virus is the leading cause of post transplant Non A Non B hepatitis 
(Roth,  1991)73.  5.6  % of  the  patients  tested  positive  for  Anti-HCV antibodies  by 
ELISA in this study.  In a study by Yuan et al (2005)95, 5.8% of the patients were 
positive for Anti - HCV antibodies  Hepatitis C  infection  occurred more commonly 
after one year post transplant (Table 19).
HEPATITIS B
1.6%  of  the  total  infectious  episodes  were  caused  by  Hepatitis  B.  All  the 
patients were positive for HBs Ag by ELISA. The HBs Ag positive individuals were 
preoperatively negative. Majority of the Hepatitis B cases occurred after one year post 
transplant  (Table  20).  In  the  study  done  by  Ravi  kumar  (1998)83,  3.5%  of  the 
infectious episodes were caused by Hepatitis B.
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WOUND INFECTION
The incidence of wound  infection  was  2.4%  (Table 4 ) in  the  present  study. 
The  reported  incidence  varies  from  0.7%  by  Kyriakides  (1975)79,  4%  by  
Desai JD.S.Jadav (1993)84, 1.3%  by Giri(1992)82 and 2.2% by Ravi kumar (1998)83. 
Bacteria was isolated in 5 patients which included two  Klebsiella pneumoniae,  two 
E.coli and one  Staph aureus. Candida albicans was isolated in one patient (Table 21). 
ajority of the wound infections occurred in the first one month post transplant period.
MALARIA
Malaria occurred in 4 patients and it constituted 1.6% of the total infectious episodes (Table 4). 
Plasmodium falciparum (2) and Plasmodium vivax (2) were the causative organisms. Two patients had 
malaria during the first month post operative period. Though 40% mortality in renal transplant recipients 
with  
Plasmodium falciparum has been  reported by Guecol I (1989)64,  no deaths have occurred due to malaria 
in the present study.
CENTRAL NERVOUS SYSTEM INFECTION
One patient developed meningitis which constituted 0.4% of the total infectious 
episodes (Table 4). Giri(1992)82  has reported the incidence of 0.7% in his study. The 
causative organism was found to be Cryptococcus neoformans. The patient developed 
meningitis in the 9th month post transplant. Ravi kumar (1998)83 also observed 2 cases 
of  Cryptococcus  neoformans  meningitis  in  his  study.  It  has  been  mentioned  that 
Cryptococcus neoformans, the single most common cause of central nervous system 
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infection  in  the  renal  transplant  patients,  occurs  almost  exclusively in  the late  post 
transplant period (more than six months after transplant ) Robert H. Rubin (1993) 9.
In the present study it was noted that infections in renal transplant patients were commonly 
caused by Bacteria(71.9%) followed by Fungi(17.4%), Viruses(6.9%) and Parasites(3.6%).   
Bacterial, Fungal and Parasitic infections occurred most commonly within 6 months of renal 
transplantation. Viral infections occurred predominantly after 6 months of transplantation.
Urinary tract infections were  the  commonest cause of infection within  one 
month  post  transplant  period  and  it  was  71.8%  (Table  22)  in  this  study.
Ravi  kumar  (1998)83 observed  the  incidence  of  68.5% of  infections  were  due  to 
urinary tract infection during the first one  month  post transplant  period. 90% of  the 
urinary  tract  infections  occurred  within  one  month  post  transplant  was  noted  by  
Mroz E et al(1993)85 and it was 70% in the present study.
In the current study out of 88 patients,10 patients died, the mortality rate was 
11.6% (Table 24). The single most common cause of death in this study was due to 
Bacteremia  (40%).  Ravi  kumar  (1998)83 observed  a  mortality  rate  of  22.5%, 
Bacteremia constituting 44.4% in his study.
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ANTIBIOGRAM (Table 25, 26)
In this study, Gram positive organisms (Staph aureus, Enterococcus fecalis, Micrococci) were 
highly sensitive to Vancomycin (100%).
 Staph  aureus showed  84.6%  sensitivity  to  Oxacillin,  76.9%  sensitivity  to 
Erythromycin  and  69.2% sensitivity  to  Ofloxacin.  The  2  isolates  that  were 
resistant to  oxacillin (MRSA) were sensitive to Vancomycin.
 Enterococcus faecalis showed 50% sensitivity to Ampicillin and Erythromycin.
 Micrococci was found to be 100% sensitive to Erythromycin and Ofloxacin.
All the Gram negative organisms isolated showed 100% sensitivity to Imipenem.
 E.coli was sensitive to Ceftazidime (96.2%), Cefaperazone(96.2%) followed by 
Ofloxacin (92%) and Ampicillin(79.2%).
 Klebsiella  sp showed  100%  sensitivity  to  Cefaperazone  and  Ceftazidime 
followed by 85% sensitivity to Gentamycin and Cefuroxime.
 Pseudomonas  aeruginosa  showed a sensitivity of  65.7% for  Cefaperazone and Ceftazidime 
followed by 63.1% sensitivity to Gentamycin.
 Proteus mirabilis was found to be 100% sensitive to Cefaperazone, Ofloxacin 
and Ampicillin.
 Acinetobacter  baumannii  showed  100%  sensitivity  to  Ceftazidime, 
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Cefaperazone, Ofloxacin and Gentamycin.
15  isolates  (2  E.coli and  13  Pseudomonas  aeruginosa)  were  found  to  be 
resistant to Third generation cephalosporin, Ceftazidime.
Among  the  15  Ceftazidime  resistant  organisms,  11  isolates  (2  E.coli and
9 Pseudomonas aeruginosa) tested positive for ESBL production.
MIC  for  Ceftazidime: 1  isolate  (E.coli)   had  a  MIC  of  64  microgram/ml.  
14 isolates (13 Pseudomonas aeruginosa & 1 E.coli) had MIC > 256 microgram/ ml.
Plasmid was extracted in 8 Pseudomonas aeruginosa isolates.
Table 27 shows isolation of Bacterial, Fungal, Viral and Parasitic infections in relation to the 
systems involved.
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                          SUMMARY AND CONCLUSION
 Eighty eight renal transplant recipients were included in the present study.
 The  predominant  age  group  undergoing  renal  transplantation  was  between  
21 - 40 yrs.
 There was a Male preponderance undergoing renal transplantation.
 Total number of infectious episodes in this study were 246.
 Urinary Tract infections (52.8%) were the commonest infection observed in this study. This was 
followed  by  Respiratory  tract  infection  (10.3%),  
Drain  infection  (9.3%),  Gastrointestinal  tract  infection  (6.9%),  
Bacteremia  (4.4%),  Skin  and  soft  tissue  infection  (4%),  Hepatitis  (3.6%),  Cytomegalovirus 
infection  (3.2%), Wound infection (2.4%), Malaria (1.6%), Central nervous system infection 
(0.4%).
 The  microorganisms  involved  in  the  infections  were  Bacteria  (71.9%),  
Fungus (17.4%), Virus (6.9%)  and  Parasite (3.6%).
 In  Urinary  tract  infection,  E.coli (39.4%)  followed  by  
Klebsiella  pneumoniae  (24.5%)  were  the  predominant  bacterial  isolates. 
Candida albicans (81.2%) were  the commonest fungus isolated.
 In Respiratory tract infections, Klebsiella pneumoniae (45.4%) and Mycobacterium tuberculosis 
(27%) were the most frequently isolated organisms. Aspergillus flavus, Aspergillus fumigatus,  
Candida albicans and Mucor were the fungi isolated.
 The majority of drain infections were caused by Pseudomonas aeruginosa followed by E.coli  
and Candida albicans.
 Among  the  Gastrointestinal  tract  infections,  Candida  albicans were  the 
commonest  fungal  isolate.  Parasites  causing  GIT  infection  included  
Ankylostoma  duodenale,  Entamoeba  histolytica  cyst  and   Strongyloides  
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stercoralis.
 Klebsiella  pneumoniae  and  Pseudomonas  aeruginosa   were  the  invasive 
bacteria  causing  Bacteremia  in  renal  transplant  recipients.
 Bacterial  causes  of  Skin  and  soft  tissue  infections  were  
Staph  aureus,  E.coli,  Pseudomonas  aeruginosa  and  
Mycobacterium  tuberculosis.  Trichophyton  rubrum,  Trichophyton 
mentagrophytes and Aspergillus flavus constituted the fungal causes of Skin and 
soft tissue infections.
 Only  6  patients  had  wound  infection.  The  organisms  isolated  were  
Klebsiella sp, Staph aureus, E.coli and Candida  albicans.
 Plasmodium falciparum and  Plasmodium vivax were  involved  as  etiological  agents  causing 
infection in 4 patients.
 Cryptococcus neoformans was isolated in one case of meningitis.
 Hepatitis  B (23.5%)  and  Hepatitis  C (29.4%)  were  the  organisms  causing  
Viral Hepatitis.
 In  the first one month post  transplant period, the most common infection was Urinary tract 
infection  (71.8%)  followed  by  Drain  infection  (17.9%).  Between  
1  to  6  months  post  transplant  duration,  Urinary tract  infections  (40.9%)  were  predominant 
followed by Respiratory tract infections (21.3%).
 Infection  by  Mycobacterium  tuberculosis occurred  predominantly  within  
one year post transplant duration.
 Viral infections (Hepatitis B, Hepatitis C, CMV) occurred predominantly after 
6 months post transplant period.
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 Gram positive bacteria showed 100% sensitivity to Vancomycin followed by Erythromycin.
 Gram negative bacteria were 100% sensitive to Imipenem followed by Cefaperazone. ESBL 
production was positive in 11 gram negative isolates.
 Plasmid was isolated in 8 Pseudomonas aeruginosa isolates. 
 The  mortality  rate  in  this  study  was  11.6%  of  which  Bacteremia  
constituted 40%.
It is clearly emphasized that early and correct recognition of infectious agents in renal transplant 
recipients during immediate and late post transplant period will improve the outcome of the patients.
In  this  study the  organisms causing infection during the immediate  and  late  post  operative 
period has been categorized and the common sensitivity pattern has been analyzed, which will give the 
treating physician a reasonable idea to suspect the system and cause of infection during the particular 
post renal transplant period.
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